UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2

Oncotarget. 2016 May 31;7(22):32946-55. doi: 10.18632/oncotarget.8783.

Abstract

The ubiquitin-dependent proteasomal degradation of proteins controls signaling and cellular survival. In this study, we found that ubiquitin associated protein 2 (UBAP2) was significantly downregulated in hepatocellular carcinoma (HCC) tissues compared with adjacent normal tissues. Furthermore, higher expression of UBAP2 in cancer tissues was correlated with good prognosis in HCC patients. Knockdown of UBAP2 significantly enhanced the invasion and proliferation of HCC cells in vitro and promoted tumor growth in vivo, while enforced expression of UBAP2 impaired the aggressive ability and tumor growth of HCC cells. Mechanistically, UBAP2 formed a complex with Annexin A2 and promoted the degradation of Annexin A2 protein by ubiquitination, and then inhibited HCC progression. Collectively, UBAP2 appears as a novel marker for predicting prognosis and a therapeutic target for HCC.

Keywords: Annexin A2; hepatocellular carcinoma; invasion; ubiquitin associated protein 2; ubiquitination.

MeSH terms

  • Annexin A2 / metabolism*
  • Biomarkers, Tumor / metabolism
  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / pathology
  • Carrier Proteins / metabolism*
  • Cell Line, Tumor
  • Cell Proliferation / physiology
  • Female
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / pathology
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Prognosis
  • Ubiquitination

Substances

  • ANXA2 protein, human
  • Annexin A2
  • Biomarkers, Tumor
  • Carrier Proteins
  • Ubap2L protein, human